Track the PharmaCorp Rx Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €96.3m. The latest transaction was disclosed on 20 August 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Dumont, James. All data is free.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate PharmaCorp Rx Inc. Strong Buy (bullish), based on 3 analysts. Average price target: CA$0.67.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,088 of 29,064 companies
28.5
score / 100
Value
33
Quality
25
FCF yld-0.2%
Earn yld-1.5%
EV/EBITDA·
ROE-2.5%
Gross mgn40%
Net mgn-6.8%
Debt/EBITDA22.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
238,000 shares@ CA$0.4262.7% of flowCommon SharesTSXSEDI:4605661
Canonical exit: 10 Feb 2026 (T+90)
14 of 14 declarations
Acerca de PharmaCorp Rx Inc.
PharmaCorp Rx Inc. es una empresa centrada en el desarrollo y la comercialización de productos farmacéuticos. Cotiza en la Bolsa de Valores de Toronto (XTSE).